Linc AB Cash Flow Conversion Efficiency
Linc AB cash flow conversion efficiency. Based on the latest financial reports, Linc AB (LINC) has a cash flow conversion efficiency ratio of -0.001x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-6.09 Million ≈ $-655.60K USD) by net assets (Skr4.51 Billion ≈ $485.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Linc AB (2018–2025)
Cash flow conversion efficiency of Linc AB from 2018 to 2025. This chart illustrates how Linc AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Linc AB stock quote for real-time trading data and today's change.
Linc AB Cash Flow Conversion Ratio Explained
Linc AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Linc AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Linc AB ranked by their cash flow conversion efficiency. Also see LINC market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BlueLinx Holdings Inc
NYSE:BXC
|
-0.093x |
|
Anhui Transport Consulting &
SHG:603357
|
0.009x |
|
Beijing Jingyeda Technology Co Ltd
SHE:003005
|
-0.012x |
|
Jinyuan Cement Co Ltd
SHE:000546
|
0.034x |
|
Three Stars NM
SHG:603578
|
0.164x |
|
Oriental Times Media Corp
SHE:002175
|
-0.009x |
|
Sampoerna Agro Tbk
JK:SGRO
|
0.034x |
|
Sichuan Shengda Forestry Industry Co Ltd
SHE:002259
|
0.164x |
Annual Cash Flow Conversion Efficiency for Linc AB (2018–2025)
The table below shows the annual cash flow conversion efficiency of Linc AB from 2018 to 2025. Review LINC FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr4.43 Billion ≈ $476.85 Million |
Skr4.25 Million ≈ $457.91K |
0.001x | -84.37% |
| 2024-12-31 | Skr4.83 Billion ≈ $519.86 Million |
Skr29.68 Million ≈ $3.19 Million |
0.006x | +126.91% |
| 2023-12-31 | Skr3.53 Billion ≈ $379.78 Million |
Skr-80.57 Million ≈ $-8.67 Million |
-0.023x | +70.88% |
| 2022-12-31 | Skr2.91 Billion ≈ $313.12 Million |
Skr-228.15 Million ≈ $-24.55 Million |
-0.078x | +19.49% |
| 2021-12-31 | Skr3.63 Billion ≈ $390.96 Million |
Skr-353.84 Million ≈ $-38.08 Million |
-0.097x | -1560.96% |
| 2020-12-31 | Skr2.49 Billion ≈ $268.42 Million |
Skr-14.63 Million ≈ $-1.57 Million |
-0.006x | -929.67% |
| 2019-12-31 | Skr1.66 Billion ≈ $178.75 Million |
Skr1.17 Million ≈ $126.34K |
0.001x | +103.83% |
| 2018-12-31 | Skr1.06 Billion ≈ $114.60 Million |
Skr-19.65 Million ≈ $-2.11 Million |
-0.018x | -- |
About Linc AB
Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and o… Read more